M6P Therapeutics Presented Data on M041, A Recombinant Enzyme Therapy, for the Treatment of Sanfilippo B Syndrome at MPS 2021
– Preclinical data provide proof of concept for recombinant human alpha-N-acetylglucosaminidase (rhNAGLU) demonstrating improved mannose…
Kinetic Deploys AI-Powered Fiber Design Platform to Connect Fiber Customers Faster
SAP Helps CHKP Group Connect Online and Offline Retail to Deliver Personalised Experiences at AV Life and FOTOMAX